SBFM
Sunshine Biopharma Inc.
Next earnings Aug 10, 2026
Last earnings -1.0% on 2026-04-09
$2.14
▲ +4.90%$2.14▼ -85.14%
over 1Y
L $2.04EODHDH $22.00
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.9%
1W+0.5%
1M-48.7%
3M-78.8%
YTD-83.3%
1Y-85.1%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Conservative balance sheet (liabilities/equity 0.31x); but unprofitable (net margin -16.5%).
Sunshine Biopharma Inc. shows $36.3M in FY2025 revenue (+4.1% YoY), a -16.5% net margin, and -25.9% ROE.
Sources: SEC EDGAR (CIK 0001402328, latest 10-Q filed 2026-05-13) · EODHD · as of 6/26/2026, 12:43:51 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.